Publication | Closed Access

The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats

Psychoactive DrugPsychiatryNeuroanatomyAddictionTriple Reuptake InhibitorPrefrontal CortexPsychopharmacologyNeuropharmacologyNeuroscienceBiological PsychiatryCentral Nervous SystemDopamineMonoamine ReleaseMedicineSocial Sciences